Bioengineering

  1. Immunokinetic Model for COVID-19 Patients

    1. Y. Fadaei
    2. F. A. Rihan
    3. C Rajivganthi

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  2. Engineering SARS-CoV-2 neutralizing antibodies for increased potency and reduced viral escape

    1. Fangzhu Zhao
    2. Celina Keating
    3. Gabriel Ozorowski
    4. Namir Shaabani
    5. Irene M. Francino-Urdaniz
    6. Shawn Barman
    7. Oliver Limbo
    8. Alison Burns
    9. Panpan Zhou
    10. Michael J. Ricciardi
    11. Jordan Woehl
    12. Quoc Tran
    13. Hannah L. Turner
    14. Linghang Peng
    15. Deli Huang
    16. David Nemazee
    17. Raiees Andrabi
    18. Devin Sok
    19. John R. Teijaro
    20. Timothy A. Whitehead
    21. Andrew B. Ward
    22. Dennis R. Burton
    23. Joseph G. Jardine

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  3. Accelerating manufacturing to enable large-scale supply of a new adenovirus-vectored vaccine within 100 days

    1. Carina C D Joe
    2. Rameswara R Segireddy
    3. Cathy Oliveira
    4. Adam Berg
    5. Yuanyuan Li
    6. Dimitrios Doultsinos
    7. Nitin Chopra
    8. Steffi Scholze
    9. Asma Ahmad
    10. Piergiuseppe Nestola
    11. Julia Niemann
    12. Alexander D Douglas

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  4. Arsenal of Nanobodies for Broad-Spectrum Countermeasures against Current and Future SARS-CoV-2 Variants of Concerns

    1. M. A. Rossotti
    2. H. van Faassen
    3. A. Tran
    4. J. Sheff
    5. J. K. Sandhu
    6. D. Duque
    7. M. Hewitt
    8. S. Wen
    9. R. Bavananthasivam
    10. S. Beitari
    11. K. Matte
    12. G. Laroche
    13. P. M. Giguère
    14. C. Gervais
    15. M. Stuible
    16. J. Guimond
    17. S. Perret
    18. G. Hussack
    19. M.-A. Langlois
    20. Y. Durocher
    21. J. Tanha

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  5. Production of novel Spike truncations in Chinese hamster ovary cells

    1. Shiaki A. Minami
    2. Seongwon Jung
    3. Yihan Huang
    4. Bradley S. Harris
    5. Matthew W. Kenaston
    6. Roland Faller
    7. Somen Nandi
    8. Karen A. McDonald
    9. Priya S. Shah

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  6. Elucidating Design Principles for Engineering Cell‐Derived Vesicles to Inhibit SARS‐CoV‐2 Infection

    1. Taylor F. Gunnels
    2. Devin M. Stranford
    3. Roxana E. Mitrut
    4. Neha P. Kamat
    5. Joshua N. Leonard

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  7. Engineering RNA viruses with unnatural amino acid to evoke adjustable immune response in mice

    1. Zhetao Zheng
    2. Yu Wang
    3. Xuesheng Wu
    4. Haoran Zhang
    5. Hongmin Chen
    6. Haishuang Lin
    7. Yuxuan Shen
    8. Qing Xia

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  8. Therapeutic downregulation of neuronal PAS domain 2 (Npas2) promotes surgical skin wound healing

    1. Yoichiro Shibuya
    2. Akishige Hokugo
    3. Hiroko Okawa
    4. Takeru Kondo
    5. Daniel Khalil
    6. Lixin Wang
    7. Yvonne Roca
    8. Adam Clements
    9. Hodaka Sasaki
    10. Ella Berry
    11. Ichiro Nishimura
    12. Reza Jarrahy

    • Curated by eLife

      Evaluation Summary:

      The authors identify a novel compound called Dwn1 that suppresses the expression of Npas2, a key gene that delays wound healing. In doing so, they identify a novel treatment strategy for incisional surgical wounds that may have broader application to the treatment of scars in general.

      (This preprint has been reviewed by eLife. We include the public reviews from the reviewers here; the authors also receive private feedback with suggested changes to the manuscript. Reviewer #1 and Reviewer #2 agreed to share their names with the authors.)

    Reviewed by eLife

    3 evaluationsAppears in 1 listLatest version Latest activity

  9. BSG/CD147 and ACE2 receptors facilitate SARS-CoV-2 infection of human iPS cell-derived kidney podocytes

    1. Titilola D. Kalejaiye
    2. Rohan Bhattacharya
    3. Morgan A. Burt
    4. Tatianna Travieso
    5. Arinze E. Okafor
    6. Xingrui Mou
    7. Maria Blasi
    8. Samira Musah

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  10. Ultrapotent and broad neutralization of SARS-CoV-2 variants by modular, tetravalent, bi-paratopic antibodies

    1. Shane Miersch
    2. Nitin Sharma
    3. Reza Saberianfar
    4. Chao Chen
    5. Francesca Caccuri
    6. Alberto Zani
    7. Arnaldo Caruso
    8. James Brett Case
    9. Michael S. Diamond
    10. Gaya K. Amarasinghe
    11. Giuseppe Novelli
    12. Sachdev S. Sidhu

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity
Previous Page 14 of 26 Next